Jacobs Levy Equity Management
TVRD

Jacobs Levy Equity Management’s Tvardi Therapeutics TVRD Stock Holding History

Jacobs Levy Equity Management’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,357
Closed -$518K – 1069
2023
Q4 		$518K Sell
19,357
-20,757
-52% -$859K ﹤0.01% 822
2023
Q3 		$2.43M Buy
40,114
+11,701
+41% +$1.1M 0.01% 531
2023
Q2 		$2.89M Buy
+28,413
New +$3.91M 0.02% 501
2022
Q2 		– Sell
-25,507
Closed -$11.2M – 1106
2022
Q1 		$11.2M Sell
25,507
-201
-0.8% -$82.5K 0.08% 275
2021
Q4 		$11.3M Buy
25,708
+960
+4% +$482K 0.08% 277
2021
Q3 		$13.8M Buy
24,748
+15,035
+155% +$7.54M 0.09% 247
2021
Q2 		$4.99M Sell
9,713
-7,212
-43% -$4.57M 0.03% 429
2021
Q1 		$13.2M Buy
16,925
+2,689
+19% +$1.84M 0.1% 236
2020
Q4 		$7.75M Buy
14,236
+3,548
+33% +$1.86M 0.07% 309
2020
Q3 		$4.9M Buy
10,688
+9,291
+665% +$5.4M 0.05% 348
2020
Q2 		$860K Buy
+1,397
New +$772K 0.01% 700
2016
Q3 		– Sell
-364
Closed -$63K – 1148
2016
Q2 		$63K Sell
364
-136
-27% -$29.6K ﹤0.01% 1119
2016
Q1 		$112K Buy
+500
New +$149K ﹤0.01% 1026

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Jacobs Levy Equity Management's TVRD Position: Q1 2024 in Review

Jacobs Levy Equity Management sold out of Tvardi Therapeutics (TVRD) in Q1 2024, closing a stake of 19,357 shares — an estimated $518K sold.

Jacobs Levy Equity Management first reported a position in TVRD in Q1 2016 and held it in 13 quarters. The position peaked at $13.8M in Q3 2021. 97 funds tracked by Wall St. Rank hold TVRD as of Q1 2024.

  • Jacobs Levy Equity Management reported no remaining Tvardi Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 19,357 Tvardi Therapeutics shares in Q1 2024, an estimated $518K.
  • Jacobs Levy Equity Management first reported a position in Tvardi Therapeutics in Q1 2016 and held it in 13 quarters.
  • Jacobs Levy Equity Management's Tvardi Therapeutics position peaked at $13.8M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2024.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.